The impact of gas exchange measurement during exercise in pulmonary sarcoidosis

Respiratory Medicine

Volumn 105, Issue 1, 2011, Pages 122-129

  Kollert, Florian ^a   Geck, Barbara ^b   Suchy, Rolf ^b   Jörres, Rudolf A ^c   Arzt, Michael ^a   Heidinger, Dominic ^a   Hamer, Okka W ^a,b   Prasse, Antje ^d   Müller Quernheim, Joachim ^d   Pfeifer, Michael ^a,b   Budweiser, Stephan ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Donaustauf Hospital   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Exercise testing; Gas exchange; Sarcoidosis

Indexed keywords

CARBON MONOXIDE; IMMUNOSUPPRESSIVE AGENT; NEOPTERIN;

ADULT; ARTICLE; BREATH ANALYSIS; CELL COMPOSITION; DISEASE ACTIVITY; DISEASE COURSE; EOSINOPHIL COUNT; EXERCISE TEST; FEMALE; FORCED VITAL CAPACITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG ALVEOLUS OXYGEN TENSION; LUNG FUNCTION; LUNG GAS EXCHANGE; LUNG LAVAGE; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOIDOSIS; THORAX RADIOGRAPHY;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CARBON MONOXIDE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PULMONARY DIFFUSING CAPACITY; PULMONARY GAS EXCHANGE; SARCOIDOSIS, PULMONARY; VITAL CAPACITY;

EID: 78649941256     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.09.007     Document Type: Article

References (35)

1. J.G. Scadding Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation Br Med J 2 5261 1961 Nov 4 1165 1172
2. R.P. Baughman, R. Shipley, S. Desai, M. Drent, M.A. Judson, and U. Costabel Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation Chest 136 2 2009 Aug 526 535
3. B. Bradley, H.M. Branley, J.J. Egan, M.S. Greaves, D.M. Hansell, and N.K. Harrison Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society Thorax 63 Suppl. 5 2008 Sep v1 58
4. M.C. Iannuzzi, B.A. Rybicki, and A.S. Teirstein Sarcoidosis N Engl J Med 357 21 2007 Nov 22 2153 2165
5. Statement on sarcoidosis Joint statement of the American Thoracic Society (ATS), the European respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999 Am J Respir Crit Care Med 160 2 1999 Aug 736 755
6. T.L. Dunn, L.C. Watters, C. Hendrix, R.M. Cherniack, M.I. Schwarz, and T.E. King Jr. Gas exchange at a given degree of volume restriction is different in sarcoidosis and idiopathic pulmonary fibrosis Am J Med 85 2 1988 Aug 221 224
7. J.D. Fulmer, W.C. Roberts, E.R. von Gal, and R.G. Crystal Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis J Clin Invest 63 4 1979 Apr 665 676
8. F.J. Martinez, and K. Flaherty Pulmonary function testing in idiopathic interstitial pneumonias Proc Am Thorac Soc 3 4 2006 Jun 315 321
9. W.G. Barros, J.A. Neder, C.A. Pereira, and L.E. Nery Clinical, radiographic and functional predictors of pulmonary gas exchange impairment at moderate exercise in patients with sarcoidosis Respiration 71 4 2004 Jul 367 373
10. M. Drent, V.J. de, M. Lenters, R.J. Lamers, S. Rothkranz-Kos, and E.F. Wouters Sarcoidosis: assessment of disease severity using HRCT Eur Radiol 13 11 2003 Nov 2462 2471
11. C. Lamberto, H. Nunes, T.P. Le, F. Duperron, D. Valeyre, and C. Clerici Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange Chest 125 6 2004 Jun 2061 2068
12. A.E. Medinger, S. Khouri, and P.K. Rohatgi Sarcoidosis: the value of exercise testing Chest 120 1 2001 Jul 93 101
13. A. Miller, L.K. Brown, M.F. Sloane, A. Bhuptani, and A.S. Teirstein Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry Chest 107 2 1995 Feb 323 329
14. H. Nakata, T. Kimoto, T. Nakayama, M. Kido, N. Miyazaki, and S. Harada Diffuse peripheral lung disease: evaluation by high-resolution computed tomography Radiology 157 1 1985 Oct 181 185
15. ATS/ACCP Statement on cardiopulmonary exercise testing Am J Respir Crit Care Med 167 2 2003 Jan 15 211 277
16. M. Wong, K. Yasufuku, T. Nakajima, F.J. Herth, Y. Sekine, and K. Shibuya Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis Eur Respir J 29 6 2007 Jun 1182 1186
17. Single-breath carbon-monoxide diffusing-capacity (Transfer-Factor) - recommendations for a standard technique - 1995 update Am J Respir Crit Care Med 152 6 1995 Dec 2185 2198
18. 2 between arterial and arterialized earlobe samples Eur Respir J 9 2 1996 186 189
19. J.E. Hansen, D.Y. Sue, and K. Wasserman Predicted values for clinical exercise testing Am Rev Respir Dis 129 2 Pt 2 1984 Feb S49 S55
20. B.J. Whipp, and K. Wasserman Alveolar-arterial gas tension differences during graded exercise J Appl Physiol 27 3 1969 Sep 361 365
21. Standardization of Spirometry, 1994 Update American Thoracic Society Am J Respir Crit Care Med 152 3 1995 Sep 1107 1136
22. A. Prasse, C. Katic, M. Germann, A. Buchwald, G. Zissel, and J. Muller-Quernheim Phenotyping sarcoidosis from a pulmonary perspective Am J Respir Crit Care Med 177 3 2008 Feb 1 330 336
23. M.W. Ziegenhagen, M.E. Rothe, M. Schlaak, and J. Muller-Quernheim Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis Eur Respir J 21 3 2003 Mar 407 413
24. J. Muller-Quernheim Sarcoidosis: immunopathogenetic concepts and their clinical application Eur Respir J 12 3 1998 Sep 716 738
25. A. Prasse, D.V. Pechkovsky, G.B. Toews, W. Jungraithmayr, F. Kollert, and T. Goldmann A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18 Am J Respir Crit Care Med 173 7 2006 Apr 1 781 792
26. A. Prasse, D.V. Pechkovsky, G.B. Toews, M. Schafer, S. Eggeling, and C. Ludwig CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis Arthritis Rheum 56 5 2007 May 1685 1693
27. J.C. Grutters, J.M. Fellrath, L. Mulder, R. Janssen, J.M. van den Bosch, and H. van Velzen-Blad Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation Chest 124 1 2003 Jul 186 195
28. H. Biller, G. Zissel, B. Ruprecht, M. Nauck, G.A. Busse, and J. Muller-Quernheim Genotype-corrected reference values for serum angiotensin-converting enzyme Eur Respir J 28 6 2006 Dec 1085 1090
29. P. Sharma, I. Smith, G. Maguire, S. Stewart, J. Shneerson, and M.J. Brown Clinical value of ACE genotyping in diagnosis of sarcoidosis Lancet 349 9065 1997 May 31 1602 1603
30. M. Drent, J.A. Jacobs, V.J. de, R.J. Lamers, I.H. Liem, and E.F. Wouters Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur Respir J 13 6 1999 Jun 1338 1344
31. A. Pietinalho, P. Tukiainen, T. Haahtela, T. Persson, and O. Selroos Early treatment of stage II sarcoidosis improves 5-year pulmonary function Chest 121 1 2002 Jan 24 31
32. M.A. Judson, R.P. Baughman, B.W. Thompson, A.S. Teirstein, M.L. Terrin, and M.D. Rossman Two year prognosis of sarcoidosis: the ACCESS experience Sarcoidosis Vasc Diffuse Lung Dis 20 3 2003 Oct 204 211
33. P.W. Boros, P.L. Enright, P.H. Quanjer, G.J. Borsboom, S.P. Wesolowski, and R.E. Hyatt Impaired lung compliance and DLCO but no restrictive ventilatory defect in sarcoidosis Eur Respir J 2010
34. H. Dressel, L. Filser, R. Fischer, M.D. de la, W. Steinhaeusser, and R.M. Huber Lung diffusing capacity for nitric oxide and carbon monoxide: dependence on breath-hold time Chest 133 5 2008 May 1149 1154
35. H.J. Kabitz, F. Lang, S. Walterspacher, S. Sorichter, J. Muller-Quernheim, and W. Windisch Impact of impaired inspiratory muscle strength on dyspnea and walking capacity in sarcoidosis Chest 130 5 2006 1496 1502